Abstract
Objectives ChatGPT is an artificial intelligence (AI) chatbot developed by OpenAI. Its extensive knowledge and unique interactive capabilities enable it to be utilized in various innovative ways in the medical field such as writing clinical notes, simplifying radiology reports. Through this study we aim to analyze its pathology knowledge to advocate its role in transforming pathology education.
Methods American Society for Clinical Pathology (ASCP) Resident Question bank (RQB) 2022 was used to test ChatGPT v4. Practice tests were created in each sub-category and were answered based on the input provided by ChatGPT. Questions that required interpretation of images were excluded. ChatGPT’s performance was analyzed and compared with the average peer performance.
Results The overall performance of ChatGPT was 56.98%, lower than that of the average peer performance of 62.81%. ChatGPT performed better on clinical pathology (60.42%) than anatomic pathology (54.94%). Furthermore, its performance was better on easy questions (68.47%) compared to intermediate (52.88%) and difficult questions (37.21%).
Conclusions ChatGPT has the potential to be a valuable resource in pathology education if trained on a larger, specialized medical dataset. Relying on it solely for the purpose of pathology training should be with caution, in its current form.
Key points
ChatGPT is an AI chatbot, that has gained tremendous popularity in multiple industries, including healthcare. We aim to understand its role in revolutionizing pathology education.
We found that ChatGPT’s overall performance in Pathology Practice Tests were lower than that expected from an AI tool, furthermore its performance was subpar compared to pathology residents in training.
In its current form ChatGPT is not a reliable tool for pathology education, but with further refinement and training it has the potential of being a learning asset.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
